Avoiding an overnight hospital stay can lead to substantial cost savings. TUNA recently received approval from the U. S. Food and Drug Administration, but many insurers do not yet reimburse for the procedure. But the vaporizing effect penetrates below the surface area being treated. As a result, underlying blood vessels are coagulated and sealed. Bleeding and fluid absorption, which can occur with TURP, are avoided.
Patients go home after an overnight hospital stay and without a urinary catheter.
TUMT Transurethral microwave therapy received FDA approval in mid-1996. However, the procedure has gotten mixed reviews from investigators. The first-generation device resulted in a favorable side effect profile, but a considerable number of patients failed to benefit from treatment. Software modifications have increased the ablative energy, but the complication rate has risen with the increase power. Once the odds-on competition for TURP , laser has fallen out of favor with some urologists.